FTC Solar, Inc (FTCI) Files $250M Mixed Shelf, Announces 35.67M Share Offering by Selling Stockholders Jun 27, 2022 06:05AM
UPDATE: UBS Starts Intra-Cellular Therapies (ITCI) at Buy Jun 13, 2022 04:54PM
Altamira Therapeutics (CYTO) Reports 89.5% and 98.9% Reduction in Viral Load Against Human Rhinovirus With its Bentrio Nasal Spray Jun 8, 2022 08:49AM
Roth Capital Upgrades FTC Solar Inc. (FTCI) to Buy Jun 6, 2022 03:19PM
Northland Capital Markets Starts FTC Solar Inc. (FTCI) at Outperform May 23, 2022 09:30AM
View Older Stories

May 16, 2022 10:29AM Form 13F-HR TCI Fund Management Ltd For: Mar 31
May 11, 2022 08:39AM Intra-Cellular Therapies (ITCI) is a Bright Spot in a Dark Earnings Season, Jefferies Reiterates Buy
May 11, 2022 05:16AM UPDATE: Roth Capital Downgrades Array Technologies (ARRY) to Neutral
May 10, 2022 07:37AM Intra-Cellular Therapies (ITCI) Tops Q1 EPS by 14c
Apr 29, 2022 06:42AM Form 13F-HR TCI Wealth Advisors, For: Mar 31
Apr 25, 2022 07:03AM Intra-Cellular Therapies (ITCI) Granted FDA Approval of New Dosage Strengths for CAPLYTA
Apr 21, 2022 12:54PM Worksport Ltd (WKSP) Gains on Deal with Hyundai America Technical Center
Apr 21, 2022 08:03AM Intra-Cellular Therapies (ITCI) Appoints E. Rene Salas to its Board
Apr 21, 2022 04:21AM UPDATE: Piper Sandler Downgrades FTC Solar Inc. (FTCI) to Underweight
Apr 13, 2022 05:47AM Needham & Company Reiterates Buy Rating, $65 Price Target on Intra-Cellular Therapies (ITCI)
Apr 11, 2022 10:16AM Eli Lilly (LLY) Reports Lebrikizumab Combined with Topical Corticosteroids Showed Significant Improvements in Disease Severity for Atopic Dermatitis
Apr 5, 2022 11:15AM Jefferies Starts TCI Express Ltd (TCIEXP:IN) at Buy
Mar 29, 2022 06:24AM Needham & Company Reiterates Intra-Cellular Therapies (ITCI) at Buy with $65 PT, Sees Caplyta's Growth Accelerating & Potentially Beating Expectations
Mar 22, 2022 07:17AM Ondas Holdings Inc. (ONDS) Reports Q4 Revenue of $0.6M, Net Loss of $7M
Mar 16, 2022 08:38AM UPDATE: FTC Solar Inc. (FTCI) PT Raised to $5 but BofA Securities Requires Proof of Margin Rebound to Upgrade
Mar 16, 2022 08:30AM FTC Solar Inc. (FTCI) PT Raised to $10 at Cowen
Mar 11, 2022 09:01AM Altamira Therapeutics (CYTO) Reports Positive In Vitro Efficacy Data for Bentrio Nasal Spray in Protecting Against Sars-CoV-2 Omicron Variant
Mar 2, 2022 08:16AM FTC Solar, Inc (FTCI) Reaffirms 2022 Financial Outlook
Mar 2, 2022 08:08AM Intra-Cellular Therapies (ITCI) PT Raised to $90 at Jefferies
Mar 1, 2022 03:55PM Intra-Cellular Therapies (ITCI) PT Raised to $71 at Goldman Sachs
Mar 1, 2022 08:22AM Needham & Company Reiterates Intra-Cellular Therapies (ITCI) at Buy, Anticipates Uptick Following Earnings
Mar 1, 2022 07:34AM Intra-Cellular Therapies (ITCI) Misses Q4 EPS by 5c
Feb 28, 2022 07:31AM Adamis Pharmaceuticals (ADMP) Says Clinical Study Assessing Tempol for the Treatment of COVID-19 Surpasses Enrollment Expectations
Feb 25, 2022 07:00AM Intra-Cellular Therapies (ITCI) PT Raised to $65 at Needham & Company
Feb 16, 2022 01:47AM Goldman Sachs Starts Intra-Cellular Therapies (ITCI) at Buy
Feb 15, 2022 06:05AM Form 13F-HR LAKE STREET ADVISORS For: Dec 31
Feb 14, 2022 10:15AM Form SC 13G/A CANADIAN PACIFIC RAILWAY Filed by: TCI Fund Management Ltd
Feb 14, 2022 10:11AM Form SC 13G/A CHARTER COMMUNICATIONS, Filed by: TCI Fund Management Ltd
Feb 14, 2022 10:08AM Form SC 13G/A BOSTON PROPERTIES INC Filed by: TCI Fund Management Ltd
Feb 14, 2022 09:26AM Form 13F-HR TCI Fund Management Ltd For: Dec 31
Feb 7, 2022 08:37AM FTC Solar, Inc (FTCI) Announces Supply Contract for APA Group's 88 MW Australian Solar Project
Jan 31, 2022 02:25PM Neurocrine Biosciences (NBIX), Intra-Cellular Therapies (ITCI), and Biohaven Pharmaceutical (BHVN) Are Top Potential Acquisition Targets for Biogen (BIIB) - Mizuho Investor Survey
Jan 27, 2022 06:51AM Alliance Data Systems (ADS) Renews Long-Term Agreement with Ulta Beauty
Jan 26, 2022 04:06PM Form SC 13D/A CANADIAN NATIONAL RAILWA Filed by: TCI Fund Management Ltd
Jan 25, 2022 04:28PM Canadian National Railway (CNI) Announces Appointment of Tracy Robinson as President and CEO
Jan 25, 2022 09:19AM Intra-Cellular Therapies' (ITCI) Bipolar Depression Therapy Showing Early Signs of an Acceleration - Jefferies
Jan 25, 2022 06:05AM Bell Buckle Holdings, Inc. (BLLB) Confirms Removal of Caveat Emptor Designation
Jan 24, 2022 12:46PM Roth Capital Downgrades FTC Solar Inc. (FTCI) to Neutral
Jan 24, 2022 09:25AM Form 13F-HR TCI Wealth Advisors, For: Dec 31
Jan 5, 2022 06:04AM Intra-Cellular Therapies (ITCI) Prices 9.52M Share Offering at $42/sh
Jan 4, 2022 09:24AM Pre-Open Stock Movers 01/04: (ISPC) (BLKB) (NXPI) Higher; (ITCI) (CNM) (AFCG) Lower (more...)
Jan 4, 2022 08:31AM GreenPower Motor Co. (GP) Announces Deliveries of 4 EV Star Cab and Chassis to TCI Trucks
Jan 3, 2022 06:12PM After-Hours Stock Movers 01/03: (BLKB) (WKEY) (OWL) Higher; (ITCI) (CNM) (AFCG) Lower (more...)
Jan 3, 2022 04:01PM Intra-Cellular Therapies (ITCI) Announces Proposed Stock Offering
Dec 21, 2021 05:14AM Eli Lilly's (LLY) lebrikizumab Demonstrated Significant Skin Improvement and Itch Relief when Combined with Topical Corticosteroids in People with Atopic Dermatitis in Third Phase 3 Study
Dec 20, 2021 11:39AM Intra-Cellular Therapies (ITCI) PT Raised to $62 at Cantor Fitzgerald on FDA Approval
Dec 20, 2021 10:17AM Intra-Cellular Therapies (ITCI) PT Raised to $88 at Canaccord Genuity Following FDA Approval
Dec 20, 2021 10:12AM Increasing unusual call option volume: ECH GRTX ITCI ARDX ICPT
Dec 20, 2021 08:58AM Intra-Cellular Therapies (ITCI) PT Raised to $59 at Needham & Company; Sees >$800M in Caplyta Sales by 2026
Dec 20, 2021 08:28AM Intra-Cellular Therapies (ITCI) PT Raised to $85 at Jefferies Following FDA Approval
View Older Stories